Physician profile
Denise E Taylor
NPI 1609896760
$7,152.09
in general payments reported to CMS, 2019-2025
16 companies · $1,359 in 2025
The $1,359 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $922 · 2020: $520 · 2021: $680 · 2022: $1,195 · 2023: $957 · 2024: $1,519 · 2025: $1,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,835.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,106.25 | 2019-2025 | Epclusa, Descovy, Yeztugo |
| Viiv Healthcare Company | $2,872.20 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Merck Sharp & Dohme LLC | $444.66 | 2019-2024 | Pifeltro, Delstrigo |
| E.R. Squibb & Sons, L.L.C. | $134.19 | 2024 | Cobenfy |
| Emd Serono, INC. | $118.20 | 2019-2020 | |
| Antares Pharma, INC. | $104.10 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $93.96 | 2022 | |
| Braeburn INC. | $67.30 | 2025 | Brixadi |
| Halozyme INC | $47.71 | 2023 | |
| Abbvie INC. | $41.69 | 2023-2024 | Mavyret |
| Tolmar, INC. | $28.49 | 2025 | Jatenzo |
| Theratechnologies INC. | $25.74 | 2023 | Trogarzo, Egrifta |
| Napo Pharmaceuticals INC | $20.11 | 2025 | Mytesi |
| Verity Pharmaceuticals INC. | $18.52 | 2025 | Tlando |
| Exact Sciences Corporation | $14.56 | 2025 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $14.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.